Background {#Sec1}
==========

Adenosine stress perfusion cardiovascular magnetic resonance (CMR) accurately detects myocardial ischemia and guides clinical decision-making \[[@CR1], [@CR2]\]. However, perfusion CMR has a reported false-negative rate of between 5 and 16% \[[@CR2]--[@CR4]\], which may lead to suboptimal management strategies. In the absence of poor image quality, inadequate adenosine stress response is the commonest cause of false-negative perfusion scans \[[@CR4]\], because conventional hemodynamic markers of stress response, such as heart rate and systolic blood pressure, are unreliable predictors of myocardial vasodilatation and the achievement of maximal hyperemia \[[@CR5]\].

Recently, the "splenic switch-off" sign was proposed as a CMR marker of adequate adenosine stress. It describes visually reduced splenic perfusion during stress imaging (spleen appears dark) compared to rest imaging (spleen appears bright) \[[@CR6]\], and in retrospective analyses, failed splenic switch-off was more commonly observed in false-negative perfusion scans than true-negatives \[[@CR6]\]. The physiological basis for this phenomenon is that splenic blood volume reduces significantly during exercise, due to splanchnic blood redistribution \[[@CR7], [@CR8]\], and can manifest as splenic "disappearance" on nuclear imaging \[[@CR9]\]. The degree of splenic blood volume reduction is proportional to exercise workload \[[@CR7]\], independent of cardiac output \[[@CR7]\], and is related to adenosine-mediated splenic vasoconstriction \[[@CR10], [@CR11]\]. More recently, splenic switch-off has been shown to relate to higher myocardial T2 values during dipyridamole stress, further suggesting a connection between splenic and myocardial vascular biology \[[@CR12]\].

A key limitation of splenic switch-off is that it can only be assessed after gadolinium first-pass perfusion imaging \[[@CR6]\], at which point it is too late to optimize stress adequacy \[[@CR13]\]. Repetition of inadequately stressed images would require a wait-period (10--15 min) for gadolinium "wash-out" from the LV cavity to optimize myocardial-blood contrast during the subsequent (no longer first-pass) stress perfusion imaging, leading to longer scan durations, and exposes patients to additional adenosine and contrast agents \[[@CR6]\]. Therefore, a method which can determine stress adequacy and offer opportunities for pre-emptive stress response optimization *before* gadolinium first-pass perfusion imaging is highly desirable.

Native T1-mapping enables quantitative characterization of tissue blood volumes without the need for gadolinium-based contrast agents (GBCA) \[[@CR14]--[@CR16]\], and offers the potential to assess stress responses before GBCA first-pass perfusion. T1 (proton spin-lattice) relaxation time is a magnetic property of tissues measured in milliseconds \[[@CR14]\], and each tissue type, including the spleen, has its own normal range of T1 values \[[@CR14]\]. T1 is sensitive to changes in tissue water content or blood volume \[[@CR15]--[@CR19]\], and we recently showed that normal myocardial T1 increases by 6% during adenosine vasodilatory stress, due to expansions in myocardial blood volume \[[@CR15], [@CR16]\]. Furthermore, stress-T1 appears sensitive to changes in normal, ischemic and infarcted myocardium, without the need for GBCA \[[@CR15]\]. Contrary to its vasodilatory effects in the myocardium, adenosine causes splenic *vasoconstriction*, reducing the splenic blood volume, and thus expected to lower the splenic T1 (T1~spleen~). Conveniently, the spleen is typically visible on stress perfusion CMR and can be inspected without additional planning.

This study sought to evaluate stress and rest T1~spleen~ as a gadolinium-free CMR marker of adenosine stress responses by comparing with the existing "splenic switch-off" sign and hemodynamic markers. We hypothesized that: (i) T1~spleen~ will decrease significantly from resting values during adenosine stress, due to splenic blood volume reductions and; (ii) stress-related changes in T1~spleen~ (ΔT1~spleen~) correlate to changes in splenic perfusion on CMR (the "splenic switch-off" sign), but without the need for GBCA.

Methods {#Sec2}
=======

All study procedures received favourable opinions from local ethics committees, and all subjects gave written informed consent.

Study population {#Sec3}
----------------

To establish the relationship between T1~spleen~ and splenic perfusion/switch-off, retrospective analysis was performed on CMR scans of 212 subjects; 104 subjects had CMR at 1.5 T (Magnetom Avanto, Siemens Healthcare, Erlangen, Germany) and 108 subjects had CMR at 3 T (Magnetom Trio a Tim system, Siemens Healthcare, Erlangen, Germany). The 1.5 T population had 75 patients (*n* = 36 known coronary artery disease \[CAD\], *n* = 39 Atrial Fibrillation \[AF\]) and 29 healthy controls; the 3 T population had 86 patients (*n* = 22 known CAD, *n* = 23 Type II Diabetes Mellitus \[DM\], *n* = 21 Severe Aortic Stenosis \[AS\], *n* = 20 Hypertrophic Cardiomyopathy \[HCM\]) and 22 healthy controls. Healthy controls had no history of cardiovascular disease, were not on regular medications, and had normal electrocardiograms.

CMR protocol {#Sec4}
------------

All subjects avoided adenosine antagonizers (e.g. caffeine) for ≥24 h before CMR. T1-mapping was performed using the Shortened Modified Look-Locker Inversion recovery (ShMOLLI) prototype sequence (WIP 561 and 448C) with inline map generation, which uses 9-heartbeats breath-holds per T1-map acquisition and enables on-screen image reconstruction within 10 s \[[@CR14]\].

Native T1-maps were acquired at rest and during peak adenosine stress (140 μg/kg/min, 4 min, IV) in short-axis (basal, mid-ventricular, apical) slices, followed immediately by first-pass perfusion imaging on matching slices during peak stress, with an IV bolus of GBCA (0.03 mmol/kg at 6 ml/s; Dotarem, Guerbet, Villepinte, France) and saline flush (15 ml at 6 ml/s) \[[@CR15], [@CR16]\]. Matching rest perfusion images were acquired \>15 min after stress perfusion and adenosine discontinuation to allow sufficient time for contrast washout \[[@CR15], [@CR16]\].

T1-mapping analysis {#Sec5}
-------------------

Separate data files containing all T1-maps were created and anonymized before analysis by an observer (\>3 years of T1-mapping analysis experience) blinded to perfusion images and clinical information. T1-maps were excluded from analysis if the spleen was not clearly visible (2%), had respiratory-motion artefacts on raw Inversion-Recovery-weighted images (3%) or had suboptimal goodness-of-fit R^2^-maps (2%) \[[@CR17], [@CR20]\]. Overall, 738 T1-maps were included in final analysis, using dedicated in-house software MC-ROI (programmed by S.K.P. in IDL, version 6.1, Exelis Visual Information Solutions, Boulder, Colorado) \[[@CR14]--[@CR18], [@CR20]\]. To estimate mean native T1~spleen~, regions of interest (ROIs) were manually placed on T1-maps to include as much splenic tissue as possible, avoiding partial volume effects from large splenic blood vessels and borders with neighbouring tissues (Fig. [1](#Fig1){ref-type="fig"}). ROIs were quality checked against corresponding Inversion-Recovery-weighted images and R^2^-maps. To derive thresholds suitable for direct application on the CMR console, splenic T1-reactivity to adenosine stress (ΔT1~spleen~) was expressed in absolute terms: ΔT1~spleen~ (ms) = StressT1~spleen~ -- RestT1~spleen~.Fig. 1Representative stress and rest splenic first-pass gadolinium perfusion and native T1-maps. Signal intensity (*SI*) curves represent splenic perfusion SI (*y-axis, arbitrary units*) over time (*x-axis, 50--60 s*). The maximum and minimum SI~spleen~ are as indicated. Splenic regions of interests on perfusion images and T1-maps are outlined in red and black, respectively. Mean native T1~spleen~ and stress changes (*ΔT1* ~*spleen*~) are as labelled. 3 T images were used for illustration (*observed ΔT1* ~*spleen*~ and *ΔSI* ~*spleen*~ *are field strength independent*)

T1~spleen~ intra-scan variability assessments {#Sec6}
---------------------------------------------

Inter-slice variability in resting T1~spleen~, stress T1~spleen~ and ΔT1~spleen~ were assessed in cases where matching stress and rest T1-maps were performed in ≥2 different short-axis slice positions. To assess for intra-slice T1~spleen~ variability, we re-analyzed healthy-volunteers data from the original ShMOLLI methods paper, where T1-maps were repeated \>15 min apart in the same short-axis slice within the same scan \[[@CR14]\]. Intra-scan variability was calculated as the standard deviation of differences-from-the-mean in each individual.

Splenic perfusion analysis {#Sec7}
--------------------------

Splenic first-pass perfusion was analysed by an observer (\>4 years of perfusion imaging analysis experience) blinded to T1-maps and clinical information, using CMR^42^ software (Circle Cardiovascular Imaging Inc., Calgary, Canada). Splenic ROIs were placed on stress and rest perfusion images with frame-by-frame manual correction for artefacts and respiratory motion, to generate curves showing mean splenic signal intensity (SI, arbitrary units) changes over time (50--60s). Peak splenic perfusion SI (SI~spleen~) was estimated as the numerical difference between baseline-SI and maximal-SI during splenic first-pass perfusion as previously described \[[@CR6]\]. Adenosine-induced changes in SI~spleen~ compared to rest were expressed in percentages: ΔSI~spleen~ (%) = (StressSI~spleen~ -- RestSI~spleen~) ÷ RestSI~spleen~ × 100%.

Splenic switch-off on perfusion imaging was visually assessed by 2 independent observers (\>3 years clinical CMR perfusion experience). In the 5/212 cases where the 2 observers disagreed, adjudication was sought from a 3^rd^ independent observer (Fig. [1](#Fig1){ref-type="fig"}). Perfusion images were graded as previously described \[[@CR6]\]: either displaying *splenic switch-off* (the spleen on rest imaging is clearly brighter than on stress imaging), or *no switch-off (*the spleen on rest imaging is of similar brightness compared to stress imaging).

Statistical analysis {#Sec8}
--------------------

Data are reported as mean ± SD, tests are 2-tailed and parametric, based on Kolmogorov-Smirnov normality-checks. Differences in individual characteristics were tested using Student's *t*-tests, paired within individuals (e.g. stress vs rest T1~spleen~) and unpaired between groups (e.g. ∆T1~spleen~ in controls vs patients). Comparisons between ≥3 data groups were assessed using analysis of variance (ANOVA) with Bonferroni-corrected post-hoc method. Linear correlations were assessed using Pearson's correlation coefficient (R) and non-linear correlations were assessed using Spearman's rank correlation coefficient (rho). Intra-scan variability and inter-observer reproducibility of rest/stress T1~spleen~ and ΔT1~spleen~ were assessed using the Intra-class correlation coefficient (ICC), reporting 95% confidence intervals. The performance of ΔT1~spleen~ for replicating splenic switch-off was assessed using receiver-operating characteristics (ROC) curves \[[@CR21]\], reporting area-under-the-curve (AUC ± SEM), and also sensitivity, specificity, diagnostic accuracy, positive predictive values (PPV) and negative predictive values (NPV), with 95% confidence intervals (CI). All analyses were performed on single measures per-subject, using MedCalc 12.7.8 (MedCalc Software, Ostend, Belgium). *P* \< 0.05 denotes statistical significance.

Results {#Sec9}
=======

Subject characteristics {#Sec10}
-----------------------

Subject characteristics are summarised in Table [1](#Tab1){ref-type="table"}. All subjects experienced at least one adenosine-related symptoms (e.g. chest-tightness, dyspnoea, flushing) \[[@CR13]\], and \>10 bpm increase in heart rate (HR) during adenosine stress, compared to rest. Significant blood pressure response (\>10 mmHg SBP decrease during stress) was observed in 50% of subjects.Table 1Characteristics of study subjects: healthy controls and patients (*n* = 212)1.5 T\
Controls\
*n* = 291.5 T\
Patients\
*n* = 753 T\
Controls\
*n* = 223 T\
Patients\
*n* = 86Age (years)54 ± 1765 ± 9\*43 ± 1260 ± 14\*Men (%)21 (72)58 (77)13 (59)58 (67)Body mass index (kg/m^2^)25 ± 428 ± 526 ± 328 ± 4Hematocrit0.42 ± 0.030.43 ± 0.030.42 ± 0.040.42 ± 0.03CMR hemodynamic data Rest HR (bpm)66 ± 1162 ± 1562 ± 1265 ± 10 Stress HR (bpm)96 ± 1579 ± 15\*95 ± 1291 ± 14 Rest SBP (mmHg)133 ± 21139 ± 19127 ± 14136 ± 19 Stress SBP (mmHg)127 ± 19133 ± 19122 ± 16126 ± 19 Rest RPP (bpm.mmHg)8800 ± 22008600 ± 22007600 ± 17008700 ± 2000 Stress RPP (bpm.mmHg)12,200 ± 260010,500 ± 2500\*12,000 ± 220011,700 ± 2700 Adenosine symptoms29 (100)75 (100)22 (100)86 (100)Co-morbidities Current smoker3 (10)2 (3)2 (9)12 (14) Ex-smoker3 (10)21 (28)3 (14)21 (24) Hypertension-28 (37)-24 (28) Hyperlipidemia-23 (31)-23 (27) Stroke/TIA-2 (3)-2 (2)Medications Aspirin-36 (48)-35 (41) Beta-blocker-34 (45)^\#^-19 (22) ACEi/ARB-36 (48)-39 (45) Statin-31 (41)^\#^-44 (51) Nitrates-3 (4)4 (5) CCB (non-DHP)-13 (17)^\#^-0 (0) CCB (DHP)4 (5)7 (8)Values are *n* (%) or mean ± SD*Abbreviations*: *RPP* rate pressure product, *TIA* transient ischemic attack, *ACEi* angiotensin-converting enzyme inhibitors, *ARB* angiotensin receptor blockers, *CCB* calcium channel antagonist, *DHP* dihydropyridine\**p* \< 0.05 compared to controls of corresponding field strength (1.5 T or 3 T). ^\#^ *p* \< 0.05 for comparisons between patient groups (1.5 T vs 3 T)

Mean stress HR was lower in 1.5 T patients compared to other subjects, despite similar resting HR, likely due to more frequent beta-blocker and non-dihydropyridine calcium channel antagonist administration in these patients (all AF/CAD, Table [1](#Tab1){ref-type="table"}).

Stress and rest T1~spleen~ in controls and patients {#Sec11}
---------------------------------------------------

In healthy controls, mean resting T1~spleen~ values were 1102 ± 66 ms (1.5 T) and 1352 ± 114 ms (3 T), which decreased significantly during adenosine stress at 1.5 T (ΔT1~spleen~: −40 ± 25 ms, *p* \< 0.0001) and 3 T (ΔT1~spleen~: −43 ± 31 ms, *p* \< 0.0001). Patients had slightly lower resting T1~spleen~ compared to controls at 1.5 T (1083 ± 59 ms vs. 1102 ± 66 ms, *p* = 0.04), and this pattern was more pronounced at 3 T (1295 ± 105 ms vs. 1352 ± 114 ms, p = 0.01). Despite these observed resting T1~spleen~ differences, ΔT1~spleen~ was comparable between patients and controls, at 1.5 T (−44 ± 21 ms vs. −40 ± 25 ms, *p* = 0.43) and 3 T (−44 ± 26 ms vs. −43 ± 31 ms, *p* = 0.93; Table [2](#Tab2){ref-type="table"}). In controls, there was a strong correlation between stress ΔT1~spleen~ (mean −4.1 ± 1.5%) and ΔT1~myocardium~ (mean 5.9 ± 1.8%), r = −0.72, *p* \< 0.001. See Additional file [1](#MOESM1){ref-type="media"} for more details.Table 2Rest and stress splenic T1 in healthy controls and patients1.5 T Controls1.5 T Patients*p*-value3 T Controls3 T\
Patients*p*-valueRest T1~spleen~ (ms)1102 ± 661083 ± 590.041352 ± 1141295 ± 1050.01Stress T1~spleen~ (ms)1061 ± 681039 ± 550.021308 ± 1141253 ± 1120.01ΔT1~spleen~ (ms)−40 ± 25−44 ± 210.43−43 ± 31−44 ± 260.93ΔT1~spleen~ = StressT1~spleen~ -- RestT1~spleen~

In pooled analysis, ΔT1~spleen~ did not appear to be significantly affected by field strength (1.5 T vs. 3 T: −43 ± 22 ms vs. −42 ± 27 ms, p = 0.89), gender (male vs. female: −40 ± 23 ms vs. −47 ± 28 ms, *p* = 0.09), age (R = 0.10, *p* = 0.14, range 21--89 years) or the type of cardiovascular diseases (1.5 T CAD −42 ± 20 ms vs. 3 T CAD −40 ± 25 ms vs. AF −46 ± 22 ms vs. HCM −43 ± 28 ms vs. AS −43 ± 21 ms vs. DM −43 ± 32 ms, p = 0.54). In addition, ΔT1~spleen~ was not significantly affected by medication in patients (supplementary material in Additional file [2](#MOESM2){ref-type="media"}).

T1~spleen~ intra-scan variability {#Sec12}
---------------------------------

Inter-slice intra-scan variability (assessable in 96 subjects) was within ±19 ms for resting T1~spleen~, ±18 ms for stress T1~spleen~, and ±10 ms for ΔT1~spleen~. Re-analysis of the original ShMOLLI cohort (spleen visible in 9/10 cases), revealed an intra-slice intra-scan repeat variability of T1~spleen~ of ±9 ms, ICC: 0.98 (95% confidence interval 0.93 to 0.99) \[[@CR14]\]. ΔT1~spleen~ was derived by a second independent blinded observer in 45 subjects (20 controls; 25 patients: 5 CAD, 5 AF, 5 DM, 5 AS, 5 HCM), which yielded an ICC of 0.87 (95% confidence interval: 0.76 to 0.93). The Bland-Altman plot for inter-observer variability is shown in supplementary material (Additional file [3](#MOESM3){ref-type="media"}).

Associations between splenic perfusion, T1 and rate pressure product (RPP) {#Sec13}
--------------------------------------------------------------------------

By semi-quantitative analysis, peak splenic perfusion SI (SI~spleen~) decreased significantly with adenosine stress compared to rest, with no differences between controls and patients, or across field strengths (Table [3](#Tab3){ref-type="table"}). ΔSI~spleen~ correlated strongly with ΔT1~spleen~ (rho = 0.70, *p* \< 0.0001, Fig. [2](#Fig2){ref-type="fig"}). In contrast, ΔSI~spleen~ and ΔT1~spleen~ did not demonstrate significant correlations with stress-induced changes in RPP (*R* = 0.04, *p* = 0.60; *R* = 0.06, *p* = 0.38, respectively).Table 3Peak splenic perfusion signal intensity (SI~spleen~) at rest and during adenosine stress (ΔSI~spleen~) in healthy controls and patients1.5 T\
Controls1.5 T Patients3 T Controls3 T Patients*p*-valueRest SI~spleen~ (au)26 ± 824 ± 1129 ± 1327 ± 130.16Stress SI~spleen~ (au)11 ± 511 ± 513 ± 1212 ± 80.10ΔSI~spleen~ (%)−58 ± 23−54 ± 22−56 ± 28−52 ± 300.51*Abbreviations*: *Au* arbitrary units*P*-values derived using ANOVA with Bonferroni post-hoc method Fig. 2Correlation between stress-induced reductions in peak splenic signal intensity (*ΔSI* ~*spleen*~) and splenic native T1 (*ΔT1* ~*spleen*~). Pooled data of controls and patients at 1.5 T (*blue*) and 3 T (*red*), represented on per-subject basis (*n* = 212). Spearman's rank correlation coefficient (*Rho*) = 0.70, *p* \< 0.0001

Visual splenic switch-off assessment -- relationships with perfusion, quantitative T1~spleen~ and hemodynamic parameters {#Sec14}
------------------------------------------------------------------------------------------------------------------------

Subjects with visual splenic switch-off had greater stress ΔSI~spleen~ and ΔT1~spleen~ values compared to those with no switch-off (Table [4](#Tab4){ref-type="table"} and Fig. [3](#Fig3){ref-type="fig"}). In contrast, there were no significant differences in stress-related haemodynamic changes (HR, SBP, RPP) between subjects with splenic switch-off and no switch-off (Table [4](#Tab4){ref-type="table"} and Fig. [3](#Fig3){ref-type="fig"}).Table 4Stress-induced changes in peak splenic perfusion signal intensity (ΔSI~spleen~), T1 (ΔT1~spleen~) and hemodynamic parameters for visually assessed "splenic switch-off" signSplenic Switch-offNo\
Switch-off*p*-valueAll subjects *n* = 212196 (92)16 (8)- Healthy volunteers *n* = 5149 (96)2 (4)- Patients *n* = 161147 (91)14 (9)-ΔSI~spleen~ (%)−62 ± 1717 ± 29\<0.0001ΔT1~spleen~ (ms)−46 ± 22−2 ± 25\<0.0001Stress hemodynamic changes Δ heart rate (bpm)19 ± 920 ± 120.83 Δ SBP (mm. Hg)−8 ± 22−10 ± 190.76 Δ RPP (bpm.mmHg)2800 ± 21002600 ± 17000.89Values are *n* (%) or mean ± SD*Abbreviations*: *Bpm* beats per minute, *SBP* systolic blood pressure, *RPP* rate pressure product Fig. 3Relations between different markers of stress adequacy. Subjects with the "splenic switch-off" sign had greater stress-induced reductions in **a** *gadolinium-based* splenic perfusion (ΔSI~spleen~, same technique) and **b** *gadolinium-free* splenic T1 (ΔT1~spleen~, different technique) compared to subjects with no switch-off. There was no difference in stress-induced **c** *hemodynamic* changes in rate pressure product (*RPP*) between the splenic switch-off and the no switch-off subjects. Data are mean ± 1SD

ROC analysis of native ΔT1~spleen~ for replicating gadolinium-based "splenic switch-off" {#Sec15}
----------------------------------------------------------------------------------------

ROC analysis using visual splenic switch-off as reference standard (true positives = splenic switch-off, true negatives = no switch-off) yielded an AUC of 0.90 ± 0.05 (*p* \< 0.0001, Fig. [4](#Fig4){ref-type="fig"}). A ΔT1~spleen~ threshold of ≥ −30 ms during adenosine stress replicated visual splenic switch-off with a sensitivity of 90% (95% CI: 85--94%, *p* \< 0.0001), specificity 88% (95% CI: 62--98%, *p* \< 0.0001), diagnostic accuracy 90% (95% CI: 84--96%, *p* \< 0.0001), PPV 98% (95% CI: 96--100%, *p* \< 0.0001) and NPV 42% (95% CI: 26--61%, *p* \< 0.0001).Fig. 4ROC curves of native ΔT1~spleen~ for replicating the gadolinium-based "splenic switch-off" sign. A ΔT1~spleen~ threshold of ≥ −30 ms replicated the "splenic switch-off" sign (AUC 0.90 ± 0.05, *p* \< 0.0001), with high sensitivity 90%, specificity 88% and diagnostic accuracy 90%

Discussion {#Sec16}
==========

This proof of principle study demonstrated that T1~spleen~ decreases significantly during adenosine stress compared to baseline. The magnitude of the stress-induced T1~spleen~ response (ΔT1~spleen~) is strongly correlated with splenic perfusion attenuation (ΔSI~spleen~). From a clinical viewpoint, a native ΔT1~spleen~ threshold of ≥ −30 ms accurately replicated the "splenic switch-off" sign with a high positive predictive value of 98% and offers the potential to assess adenosine stress adequacy before GBCA first-pass perfusion imaging. From a practical viewpoint, assessment of T1~spleen~ takes \~30 s (Fig. [5](#Fig5){ref-type="fig"}), which means it can be repeated as necessary "on-the-fly", to guide adenosine dosage up-titrations and optimize stress responses before injection of contrast agents (example protocol in Fig. [5](#Fig5){ref-type="fig"}). This pre-gadolinium approach may be advantageous over the retrospective and potentially gadolinium dose-sensitive splenic switch-off method for improving the quality of stress responses before first-pass perfusion imaging, which deserves further investigation in future studies to determine whether it decreases the number of false negative perfusion scans \[[@CR6]\].Fig. 5Potential splenic ΔT1~spleen~-guided protocol for real-time assessment and optimization of stress adequacy before gadolinium perfusion. Practical T1~spleen~ assessment using ShMOLLI typically takes around 30 s: breath-hold instructions (*5 s*), T1-map acquisition over 9-heart-beats (\~10 s, shorter with higher stress heart rates), on-screen image reconstruction (*5*--*10 s*), splenic-ROI placement directly on CMR console screen by the operator (*5 s*) followed by immediate display of T1~spleen~/SD estimations (as indicated). The ability of this protocol to improve the quality of stress responses deserves validation in future studies

Stress/rest T1~spleen~ as a marker of adenosine stress response {#Sec17}
---------------------------------------------------------------

Patients had lower resting native T1~spleen~ values compared to controls. This may be related to the presence of co-morbidities in patients, such as hypertension and peripheral vascular disease, which may induce peripheral vasoconstriction, with expected reductions in resting organ blood volumes and T1~spleen~ values. This observation deserves further investigation in larger future studies. Native T1-relaxation times of tissues are prolonged by increased blood volume (i.e. water content) \[[@CR14], [@CR15], [@CR22]\]. Adenosine causes splenic artery vasoconstriction and reduced blood volume \[[@CR6]--[@CR11]\], which shortens splenic T1-relaxation times. This is supported by our observation of significantly lower T1~spleen~ during adenosine stress compared to rest, in both controls and patients. The stress ΔT1~spleen~ was not significantly affected by different field strengths, age, gender and cardiovascular diseases, likely reflecting reproducible T1-estimations in this study \[[@CR14], [@CR15], [@CR22]\].

The correlation between stress ΔT1~spleen~ and ΔT1~myocardium~ in normal controls suggests the vasoconstrictor effect of adenosine on the spleen is associated with vasodilatory effects in the myocardium. For the relationship between myocardial and splenic stress T1 in patients with cardiovascular disease, larger ongoing studies will offer reference ranges for ΔT1 in disease, and resolve the separate effects of regional myocardial differences and medication on stress T1 reactivity.

The observed strong correlation between ΔT1~spleen~ and ΔSI~spleen~ suggests that stress-induced changes in splenic blood volume are related to blood flow, which is regulated by alterations in the adenosine-mediated splenic arterial tone \[[@CR10], [@CR11]\]. The lack of significant correlation between ΔSI~spleen~ or ΔT1~spleen~ with rate pressure product is consistent with existing evidence showing dissociation between imaging and hemodynamic markers of stress response \[[@CR5], [@CR6]\], and further suggests that stress responses during clinical CMR cannot be reliably assessed using hemodynamic observations alone \[[@CR5]\]. This deserves further investigation.

A threshold of ≥30 ms decrease in T1~spleen~ replicated complete splenic switch-off with a high positive predictive value of 98%. The intra-scan variability in T1~spleen~ (inter-slice: ±10 ms; intra-slice: ±9 ms) was 3-times less than this proposed threshold ≥30 ms drop, with excellent T1-fit as evident on quality control R^2^-maps, despite the lack of dedicated image optimization (e.g. shimming) over the spleen. For stress T1~spleen~ responses \<30 ms, further work is needed to determine whether adenosine dose-increments or waiting longer with the same infusion rate may improve the confidence of stress responses, and impact on diagnostic performance of stress CMR for the diagnosis of ischemia.

Limitations and future directions {#Sec18}
---------------------------------

This proof-of-concept study is based on ShMOLLI T1~spleen~ values derived from short-axis slices planned for myocardial perfusion CMR imaging; the spleen was not visible in a small proportion of T1-maps (\~2%), and future applications of splenic T1-mapping may benefit from a dedicated image planned through the spleen. Rapid on-scanner T1-map reconstructions, with the immediate availability of goodness-of-fit measures (such as R^2^-maps), are imperative to enable practical "on-the-fly" repetition of reliable T1~spleen~ estimations to guide stress response optimization (Fig. [5](#Fig5){ref-type="fig"}). Given the overall excellent R^2^-maps over the spleen and the narrow T1~spleen~ ranges obtained, data in this study suggest that stress/rest splenic T1-mapping can be feasibly included in CMR protocols without major technical adjustments. Practical in-vivo T1-estimations are method-dependent, and demonstrate increasingly discrepant heart rate dependencies at longer T1-values \[[@CR23]\]. Therefore, results achieved with ShMOLLI, in particular the splenic T1-thresholds replicating splenic switch-off, should be interpreted with care before directly translating to other T1-mapping techniques. Choosing methods that can withstand dynamic HR-variations and tachycardia without significant HR-dependencies is therefore paramount when performing stress-T1 studies. The gadolinium-based splenic switch-off sign is only seen with non-selective adenosine receptor agonists (dipyridamole and adenosine), but was absent with cardio-selective vasodilators (e.g. regadenoson) or inotropic agents (e.g. dobutamine) \[[@CR6]\]. Further work is needed to elucidate stress T1~spleen~ responses using pharmacological agents other than adenosine and during physical exercise. Patients in this study were unselected for diseases known to affect splenic blood volumes, e.g. venous portal hypertension, hematological malignancies and systemic inflammation; thus, further studies to characterize the effects of these diseases on T1~spleen~ will help to determine the general applicability of this technique. While we identified a cut-off of ≥30 ms drop in T1~spleen~ during stress for replicating complete splenic switch-off, the clinical utility of this threshold for detecting *true* stress adequacy needs to be validated against false-negative perfusion scans, determined by comparison to invasive coronary angiography and pressure-wire based assessments of functional ischemia, such as fractional flow reserve. This is topic of ongoing work.

Conclusions {#Sec19}
===========

Adenosine stress and rest splenic T1-mapping is a novel method for assessing stress responses, independent of conventional hemodynamic parameters. It enables prediction of the visual "splenic switch-off" sign without the need for gadolinium, and correlates well to changes in splenic signal intensity during stress/rest perfusion imaging. ΔT1~spleen~ holds promise to facilitate optimization of stress responses before gadolinium first-pass perfusion CMR.

Additional files {#Sec20}
================
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